California Nanotechnologies Q1 FY27 adjusted EBITDA loss narrows 15.5% to US$129,031; revenue rises 28% to US$917,854

Reuters2026/07/30 11:20

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

California Nanotechnologies posted Q1 FY2027 revenue of US$917,854, up 28% year over year.
Net loss was US$449,598; diluted loss per share was US$0.01.
Gross margin fell 12 percentage points to 45%.
Adjusted EBITDA loss (non-IFRS) narrowed to US$129,031 from a loss a year earlier as revenue rose.
Management targeted FY2027 traction in small modular reactor supply chains, aiming for larger-scale manufacturing contracts and partnerships.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. California Nanotechnologies Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607300700NEWSFILECNPR____20260730_307223_1) on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

California Nanotechnologies Q1 FY27 adjusted EBITDA loss narrows 15.5% to US$129,031; revenue rises 28% to US$917,854

You may also like

Crypto prices